mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.03 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.03 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.04 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
Bax channel blocker |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.04 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |